Biofrontera
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $10,084 | $17,100 | $6,988 | $9,030 |
Gross Profit | 8,253 | 16,229 | 4,922 | 6,362 |
EBITDA | -4,320 | 6,978 | -6,071 | -4,857 |
EBIT | 6,758 | -6,278 | -5,079 | |
Net Income | -4,752 | 5,640 | -6,649 | -5,324 |
Net Change In Cash | 10,084 | 17,100 | 6,988 | 9,030 |
Free Cash Flow | -75 | -2,375 | -3,822 | -3,046 |
Cash | 6,317 | 6,392 | 3,417 | 7,239 |
Basic Shares | 11,683 | 11,648 | 10,776 | 9,351 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $41,705 | $37,303 | $34,071 | $28,674 |
Gross Profit | 32,802 | 18,696 | 16,627 | 13,489 |
EBITDA | -8,280 | -14,441 | -18,453 | 934 |
EBIT | -9,148 | -15,590 | -19,517 | -238 |
Net Income | -10,536 | -17,759 | -20,131 | -640 |
Net Change In Cash | 41,705 | 37,303 | 34,071 | 28,674 |
Free Cash Flow | -13,363 | -10,330 | -24,900 | -16,237 |
Cash | 6,392 | 5,905 | 1,343 | 17,208 |
Basic Shares | 11,648 | 5,516 | 1,546 | 1,056 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.41 |
2025-12-31 | $0.49 |
2025-09-30 | -$0.62 |
2025-06-30 | -$0.57 |